GlassScriptPhysician profile
Kimberly Jo Pollock
NPI 1932573318
$7,165.54
in general payments reported to CMS, 2019-2025
49 companies · $23.83 in 2025
The $23.83 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,067 · 2022: $2,078 · 2023: $2,235 · 2024: $761 · 2025: $23.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,984 · Education: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,984.42 |
| Education | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $663.44 | 2021-2024 | Ingrezza, Ongentys |
| Abbvie INC. | $622.16 | 2021-2024 | |
| Biogen, INC. | $576.88 | 2021-2024 | Vumerity, Tysabri, Aduhelm |
| Novartis Pharmaceuticals Corporation | $426.74 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $417.53 | 2021-2024 | Austedo Xr, Austedo |
| Emd Serono, INC. | $410.31 | 2021-2024 | Mavenclad |
| Ucb, INC. | $369.45 | 2021-2023 | Nayzilam, Briviact |
| Sk Life Science, INC. | $326.54 | 2021-2024 | |
| Lilly USA, LLC | $280.77 | 2021-2024 | Amyvid, Reyvow, Emgality |
| Argenx US, INC. | $270.12 | 2022-2023 | Vyvgart, Vyvgart Hytrulo |
| Kyowa Kirin, INC. | $230.20 | 2021-2024 | Nourianz |
| Eisai INC. | $217.49 | 2021-2024 | |
| Avanir Pharmaceuticals, INC. | $212.52 | 2021-2022 | |
| Genentech USA, INC. | $174.51 | 2022-2024 | Ocrevus |
| Lundbeck LLC | $150.52 | 2021-2024 | Rexulti, Vyepti |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Pollock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.